The FDA Recalls Cinnamon Due to Elevated Lead Levels
FDA recalls cinnamon due to potential lead contamination
Evidence dossier
Intelligence passport
Measured timeline
Coverage (5)
-
-
-
-
Ground cinnamon sold in 6 states recalled. See affected productUSA Today · 6h ago
-
The FDA Recalls Cinnamon Due to Elevated Lead LevelsEatingWell · 6h ago
What happened
- Velocity & Diffusion: Coverage exploded across 5 distinct news outlets with 5 published articles, achieving a live velocity of 14.
- Primary Driver: FDA recalls cinnamon due to potential lead contamination
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
The FDA has recalled ground cinnamon sold in six states due to potentially elevated lead levels. The affected product is sold in stores in Texas, Arizona, California, Florida, New York, and Pennsylvania.
The FDA has not specified the exact amount of lead in the cinnamon, but has warned consumers to discard the product immediately. The recall was announced by the FDA and is reported by multiple sources, including KHOU and EatingWell.
The FDA has not provided further information on the source of the lead contamination or the extent of the issue.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (83% supported) Updated 1h ago.
Questions people are asking
Which states are affected by the recall?
Texas, Arizona, California, Florida, New York, and Pennsylvania
What should consumers do with the affected product?
Discard the product immediately
Has the FDA specified the exact amount of lead in the cinnamon?
No
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Topics
From around our network
Related trends
Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
Kyverna's 1-year miv-cel data resets conversation with autoimmune CAR-T peers hitting safety snags
FDA Announces Recall on Blood Pressure Medication—More Than 13,000 Bottles Affected Nationwide
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
FDA elevates thyroid tablet recall to most serious level
FDA raises thyroid tablet recall to highest risk level
One blood test could screen you for 50 cancers. Here’s why it’s controversial.
A Mayo‑Clinic blood test that flags over 50 cancers clears an FDA panel, sparking debate over its imminent approval.
FDA panel endorses first-of-a-kind cancer blood test from Grail
FDA panel endorses first-of-a-kind cancer blood test from Grail, but controversy lingers.
Recall alert: 13K bottles of blood pressure medication recalled - WSB-TV
FDA issues urgent recall for 13,000+ bottles of blood pressure medication.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.